To assess the relevance of TIGIT in GBM, TIGIT expression was analyzed by immunohistochemistry (IHC) on murine glioma tissue (GL261 model, Fig. 1A), and by using single-cell (sc)RNAseq data of patient glioma samples (Fig. 1B,C). This evidence concerns the gene TIGIT and central nervous system cancer.